The trajectory of Sildenafil presents a complex case for stakeholders in the pharmaceutical sector. While initially a tremendous success, creating huge profits, the intellectual property expiration and the subsequent https://gambling713719.blogofoto.com/73248748/the-little-copyright-and-pharma-a-hazardous-play